Safety and pharmacokinetics of liposomal curcumin in healthy subjects:A randomized placebo-controlled double blind first-in human study.

被引：0

作者：

Storka, Angela ^{[1
]}

Wolzt, Michael ^{[1
]}

Vcelar, Brigitta ^{[2
]}

Bolger, Gordon ^{[3
]}

Majeed, Muhammed ^{[4
]}

Helson, Lawrence ^{[5
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Polymun Sci GmbH, Vienna, Austria

[3] Nucro Tech Inc, Scarborough, ON, Canada

[4] Sabinsa Inc, East Windsor, NJ USA

[5] Sign Path Pharma, Quakertown, PA USA

来源：

CANCER RESEARCH | 2013年 / 73卷 / 08期

关键词：

D O I：

10.1158/1538-7445.AM2013-LB-165

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB165

引用

页数：1

共 50 条

[21] Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects A Randomized, Double-Blind, Placebo-Controlled, Phase I Study
Derks, Michael
Anzures-Cabrera, Judith
Turnbull, Lynn
Phelan, Mary
CLINICAL DRUG INVESTIGATION, 2011, 31 (05) : 325 - 335
[22] A randomized, double-blind placebo-controlled study of the safety of apadenoson in subjects with mild or moderate asthma
Williams, S. P.
Mcardle, J. R.
Colice, G.
Lankford, A.
Kajdasz, D. K.
Reed, C. R.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A95 - A96
[23] A First-In-Human, Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ketamine in Healthy Volunteers
Silman, Daniel
Gadelrab, Romayne
Qureshi, Mutahira
Stein, Hans
Mehta, Mitul
Carmelline, Pietro
Young, Allan
Reilly, Carmel
Duncan, Graeme
Juruena, Mario
NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 155 - 155
[24] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy Volunteers
Fukumura, Kazuya
Yokota, Takaaki
Baba, Yuko
Camilo, Juan
Ferreira, Arjona
GASTROENTEROLOGY, 2016, 150 (04) : S537 - S538
[25] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
Fukumura, Kazuya
Yokota, Takaaki
Baba, Yuko
Ferreira, Juan Camilo Arjona
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
[26] Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Tan, Karen M. L.
Chee, Jolene
Lim, Kezlyn L. M.
Ng, Maisie
Gong, Min
Xu, Jia
Tin, Felicia
Natarajan, Padmapriya
Lee, Bee Lan
Ong, Choon Nam
Tint, Mya Thway
Kee, Michelle Z. L.
Muller-Riemenschneider, Falk
Gluckman, Peter D.
Meaney, Michael J.
Kumar, Mukkesh
Karnani, Neerja
Eriksson, Johan G.
Nandanan, Bindu
Wyss, Adrian
Cameron-Smith, David
NUTRIENTS, 2023, 15 (10)
[27] Cardiovascular safety and pharmacokinetics of almotriptan:: a randomized, double-blind, placebo-controlled, crossover clinical trial in healthy volunteers
Salvà, M
Jansat, JM
Martínez-Tobed, A
CEPHALALGIA, 2003, 23 (07) : 706 - 706
[28] The Efficacy of the Novel Bioavailable Curcumin (Cureit) in the Management of Sarcopenia in Healthy Elderly Subjects: A Randomized, Placebo-Controlled, Double-Blind Clinical Study
Varma, Karthik
Amalraj, Augustine
Divya, Chandradhara
Gopi, Sreeraj
JOURNAL OF MEDICINAL FOOD, 2021, 24 (01) : 40 - 49
[29] Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers - A randomized, placebo-controlled, double-blind, multi-dose study
Visich, JE
Zuckerman, LA
Butine, MD
Gunewardena, KA
Wild, R
Morton, KM
Reynolds, TC
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (04) : 802 - 807
[30] Randomized, double-blind, placebo-controlled phase 1 study to evaluate the safety and pharmacokinetics of high doses of ubiquinol in healthy adults
Mitsui, Jun
Matsukawa, Takashi
Tanaka, Masaki
Saito-Sato, Naoko
Nakamoto, Fumiko Kusunoki
Yasuda, Tsutomu
Naruse, Hiroya
Matsukawa, Miho Kawabe
Ishiura, Hiroyuki
Nagase, Midori
Yamamoto, Yorihiro
Kuzuyama, Haruko
Wada, Ikue
Ga, Toshio
Yamazaki, Tsutomu
Moritoyo, Takashi
Tsuji, Shoji
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2022, 10 (01): : 14 - 24

← 1 2 3 4 5 →